Search Results | Cancer Research | American Association for Cancer Research

1-20 of 88

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Abstract 1208: Denoising spatial expression profiling data based on in situ position and image information

Yunguan Wang, Bing Song, Shidan Wang, Mengyi Chen, Yang Xie, Guanghua Xiao, Li Wang, Tao Wang

Cancer Res (2022) 82 (12_Supplement): 1208.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1208

Published: 15 June 2022

View article

Journal Articles

Abstract 3930: AI-driven discovery and profiling of GTAEXS-617, a selective and highly potent inhibitor of CDK7

Jérémy Besnard, James Joseph, Haiyun Bai, Ross A. Paveley, Tao Wang, Olivier R. Barbeau, Xiao-Hui Gu, Andrew S. Bell, Mate Somlyay, Christina Taubert, Christophe Boudesco, Gregory Vladimer, Fred Aswad

Cancer Res (2022) 82 (12_Supplement): 3930.

DOI: https://doi.org/10.1158/1538-7445.AM2022-3930

Published: 15 June 2022

View article

Journal Articles

Abstract 3564: Vaccination using different platforms encoding HER2-LAMP with heterologous boosting enhances adaptive HER2-specific immunity to enable potent anti-tumor responses

Robert D. Marek, Alan Chen, Renhuan Xu, Junping Wei, Tao Wang, Xiao Yang, Gangjun Lei, Teri Heiland, Zachary C. Hartman

Cancer Res (2022) 82 (12_Supplement): 3564.

DOI: https://doi.org/10.1158/1538-7445.AM2022-3564

Published: 15 June 2022

View article

Journal Articles

Abstract 3531: Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression

Bin-Jin Hwang, Li-Chung Tsao, Chaitanya Acharya, Timothy Trotter, Pankaj Agarwal, Tao Wang, Junping Wei, Xiao-Yi Yang, Gang-jun Lei, Takuya Osada, Herbert Kim Lyerly, Michael A. Morse, Zachary Hartman

Cancer Res (2022) 82 (12_Supplement): 3531.

DOI: https://doi.org/10.1158/1538-7445.AM2022-3531

Published: 15 June 2022

View article

Journal Articles

Abstract 2451: Dormant mammary tumors resist antigen-specific killing and regulate systemic immunity in association with PTN and DKK3

Timothy N. Trotter, Delila Serra, Carina Dagotto, Tao Wang, Xiao Yang, Junping Wei, Gangjun Lei, H. Kim Lyerly, Zachary C. Hartman

Cancer Res (2022) 82 (12_Supplement): 2451.

DOI: https://doi.org/10.1158/1538-7445.AM2022-2451

Published: 15 June 2022

View article

Journal Articles

Abstract P5-07-01: Proteogenomic analysis of differential chemotherapy responses in patient-derived xenografts of triple-negative breast cancer

Cancer Res (2022) 82 (4_Supplement): P5-07-01.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-07-01

Published: 15 February 2022

View article

Journal Articles

Abstract PD2-01: A platform of CDK4/6 inhibitor-resistant patient-derived breast cancer organoids illuminates mechanisms of resistance and therapeutic vulnerabilities

Cancer Res (2022) 82 (4_Supplement): PD2-01.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD2-01

Published: 15 February 2022

View article

Journal Articles

Abstract P1-21-04: The real word study on clinical features and prognostic factors of Chinese breast cancer patients with brain metastasis

Tao Wang, Huiqiang Zhang, Feng Li, Xia Wu, Jinmei Zhou, Shao hua Zhang, Li Bian, Ze fei Jiang

Cancer Res (2022) 82 (4_Supplement): P1-21-04.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-21-04

Published: 15 February 2022

View article

Journal Articles

Abstract PD8-05: Overall survival (OS) results from the phase III PHENIX trial of HER2+ metastatic breast cancer treated with pyrotinib plus capecitabine

Zefei Jiang, Min Yan, Li Bian, Tao Wang, Xichun Hu, Qingyuan Zhang, Quchang Ouyang, Jifeng Feng, Yongmei Yin, Tao Sun, Zhongsheng Tong, Xiaojia Wang, Herui Yao, Shuping Jiang, Xiaoyu Zhu, Jianjun Zou

Cancer Res (2022) 82 (4_Supplement): PD8-05.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD8-05

Published: 15 February 2022

View article

Journal Articles

A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis

Cancer Res (2021) 81 (17): 4441–4454.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-1112

Published: 01 September 2021

View article

Includes: Supplementary data

Journal Articles

Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non–Small Cell Lung Cancer Growth

Chen Wang, Xiangfeng Meng, Yu Zhou, Jing Yu, Qing Li, Zhicong Liao, Yuanyuan Gu, Jiayi Han, Shuo Linghu, Zichen Jiao, Tao Wang, Chen-Yu Zhang, Xi Chen

Cancer Res (2021) 81 (13): 3509–3524.

DOI: https://doi.org/10.1158/0008-5472.CAN-19-3806

Published: 01 July 2021

View article

Includes: Supplementary data

Journal Articles

Abstract 1956: Lycorine promotes cell senescence of hepatocellular carcinoma by regulating CDK1

Haiyang Yu, Shuangshuang Yin, Yuling Qiu, Yanming Luo, Gaoyong Hu, Jia Lu, Shiyue Zhou, Tao Wang

Cancer Res (2021) 81 (13_Supplement): 1956.

DOI: https://doi.org/10.1158/1538-7445.AM2021-1956

Published: 01 July 2021

View article

Journal Articles

Abstract 2992: Proteogenomic characterization of triple-negative breast cancer patient-derived xenografts reveals molecular correlates of differential chemotherapy response and potential therapeutic targets to overcome resistance

Cancer Res (2021) 81 (13_Supplement): 2992.

DOI: https://doi.org/10.1158/1538-7445.AM2021-2992

Published: 01 July 2021

View article

Journal Articles

Abstract PS13-14: A randomized, opened, phase II trial assessing the efficacy and safety of ATH-TH(doxorubicin/docetaxel/trastuzumab followed by docetaxel/trastuzumab) versus TCH(docetaxel/carboplatin/trastuzumab) as neoadjuvant treatment in HER2-positive breast cancer

Tao Wang, Jin-Mei Zhou, Xiao-Peng Hao, Hui-Qaing Zhang, Shao-Hua Zhang, Li Bian, Ze-Fei Jiang

Cancer Res (2021) 81 (4_Supplement): PS13-14.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS13-14

Published: 15 February 2021

View article

Journal Articles

Abstract PD15-03: LGR4 engages a wnt-independent mechanism to enhance EGFR signaling and promote metastasis of triple-negative breast cancer

Fei Yue, Weiyu Jiang, Amy T Ku, Adelaide IJ Young, Weijie Zhang, Eric P Souto, Yankun Gao, Zhihan Yu, Yi Wang, Chad J Creighton, Chandandeep Nagi, Tao Wang, Xin-Hua Feng, Shixia Huang, Cristian Coarfa, Xiang H.-F. Zhang, Qingyun Liu, Xia Lin, Yi Li

Cancer Res (2021) 81 (4_Supplement): PD15-03.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD15-03

Published: 15 February 2021

View article

Journal Articles

Abstract 2997: Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK+ NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial

Cancer Res (2020) 80 (16_Supplement): 2997.

DOI: https://doi.org/10.1158/1538-7445.AM2020-2997

Published: 15 August 2020

View article

Journal Articles

Abstract 220: Disease monitoring of mycosis fungoides via high throughput sequencing of CDR3

Kevin Y. Wang, Tao Wang, Yuehua Liu, Christine Lian

Cancer Res (2020) 80 (16_Supplement): 220.

DOI: https://doi.org/10.1158/1538-7445.AM2020-220

Published: 15 August 2020

View article

Journal Articles

Abstract 6383: HTBPI inhibits liver tumorigenesis by combined inhibition of Akt

Haiyang Yu, Hongwei Liu, Qian Chen, Xu Pang, Shuangshuang Yin, Kailong Wang, Rui Wang, Tao Wang, Yuling Qiu

Cancer Res (2020) 80 (16_Supplement): 6383.

DOI: https://doi.org/10.1158/1538-7445.AM2020-6383

Published: 15 August 2020

View article

Journal Articles

Abstract 6694: Highly selective anti-CCR8 antibody-mediated depletion of regulatory T cells leads to potent antitumor activity alone and in combination with anti-PD-1 in preclinical models

Ruth Lan, Amy Jhatakia, Joseph Campbell, Nathan Siemers, Kai Lu, Mohammed Nasser, Tetiana Grigoriev, Priti Singh, Logan Vlach, Tim Sproul, Chengyue Zhang, Xi-Tao Wang, Olufemi Adelakun, Felix Findeisen, Pavel Strop, Arvind Rajpal, Natalie Bezman, Michael Quigley, Renu Jain

Cancer Res (2020) 80 (16_Supplement): 6694.

DOI: https://doi.org/10.1158/1538-7445.AM2020-6694

Published: 15 August 2020

View article

Journal Articles

IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils

Timothy N. Trotter, Casey W. Shuptrine, Li-Chung Tsao, Robert D. Marek, Chaitanya Acharya, Jun-Ping Wei, Xiao-Yi Yang, Gangjun Lei, Tao Wang, Herbert Kim Lyerly, Zachary C. Hartman

Cancer Res (2020) 80 (15): 3088–3100.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-3825

Published: 04 August 2020

View article

Includes: Supplementary data

2 3 4 5

NARROW

Abstract 1208: Denoising spatial expression profiling data based on in situ position and image information

Abstract 3930: AI-driven discovery and profiling of GTAEXS-617, a selective and highly potent inhibitor of CDK7

Abstract 3564: Vaccination using different platforms encoding HER2-LAMP with heterologous boosting enhances adaptive HER2-specific immunity to enable potent anti-tumor responses

Abstract 3531: Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression

Abstract 2451: Dormant mammary tumors resist antigen-specific killing and regulate systemic immunity in association with PTN and DKK3

Abstract P5-07-01: Proteogenomic analysis of differential chemotherapy responses in patient-derived xenografts of triple-negative breast cancer

Abstract PD2-01: A platform of CDK4/6 inhibitor-resistant patient-derived breast cancer organoids illuminates mechanisms of resistance and therapeutic vulnerabilities

Abstract P1-21-04: The real word study on clinical features and prognostic factors of Chinese breast cancer patients with brain metastasis

Abstract PD8-05: Overall survival (OS) results from the phase III PHENIX trial of HER2+ metastatic breast cancer treated with pyrotinib plus capecitabine

A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis

Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non–Small Cell Lung Cancer Growth

Abstract 1956: Lycorine promotes cell senescence of hepatocellular carcinoma by regulating CDK1

Abstract 2992: Proteogenomic characterization of triple-negative breast cancer patient-derived xenografts reveals molecular correlates of differential chemotherapy response and potential therapeutic targets to overcome resistance

Abstract PS13-14: A randomized, opened, phase II trial assessing the efficacy and safety of ATH-TH(doxorubicin/docetaxel/trastuzumab followed by docetaxel/trastuzumab) versus TCH(docetaxel/carboplatin/trastuzumab) as neoadjuvant treatment in HER2-positive breast cancer

Abstract PD15-03: LGR4 engages a wnt-independent mechanism to enhance EGFR signaling and promote metastasis of triple-negative breast cancer

Abstract 2997: Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK+ NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial

Abstract 220: Disease monitoring of mycosis fungoides via high throughput sequencing of CDR3

Abstract 6383: HTBPI inhibits liver tumorigenesis by combined inhibition of Akt

Abstract 6694: Highly selective anti-CCR8 antibody-mediated depletion of regulatory T cells leads to potent antitumor activity alone and in combination with anti-PD-1 in preclinical models

IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only